FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200548846> ?p ?o ?g. }

• W4200548846 endingPage "283" @default.
• W4200548846 startingPage "273" @default.
• W4200548846 abstract "To evaluate the efficacy and safety of filgotinib for Japanese patients with rheumatoid arthritis (RA) and limited or no prior methotrexate (MTX) exposure.Data up to 24 weeks were analysed for 71 Japanese patients from a 52-week global Phase 3 study. Patients with RA and limited or no prior MTX exposure were randomised in a 2:1:1:2 ratio to filgotinib 200 mg plus MTX, filgotinib 100 mg plus MTX, filgotinib 200 mg, or MTX. Maximum MTX dose was 15 mg/week. Primary endpoint was proportion achieving 20% improvement in American College of Rheumatology criteria (ACR20) at Week 24.Week 24 ACR20 rates in Japanese patients were 82.6%, 90.9%, 83.3%, and 80.0% for filgotinib 200 mg plus MTX, filgotinib 100 mg plus MTX, filgotinib 200 mg, and MTX, respectively. Greater ACR20 rates with filgotinib vs MTX occurred at Week 2. Greater proportions receiving filgotinib vs MTX achieved DAS28-CRP <2.6 at Weeks 12 and 24. Adverse event rates were comparable across treatments and between the Japanese and overall populations.While Week 24 ACR20 rates were similar, filgotinib provided faster responses and higher remission rates vs MTX. In Japanese patients with RA and limited or no prior MTX exposure, filgotinib was generally well tolerated." @default.
• W4200548846 created "2021-12-31" @default.
• W4200548846 creator A5006123817 @default.
• W4200548846 creator A5006840017 @default.
• W4200548846 creator A5010781580 @default.
• W4200548846 creator A5015953107 @default.
• W4200548846 creator A5027087975 @default.
• W4200548846 creator A5028937405 @default.
• W4200548846 creator A5034591782 @default.
• W4200548846 creator A5041444521 @default.
• W4200548846 creator A5066463687 @default.
• W4200548846 creator A5067668860 @default.
• W4200548846 creator A5075601927 @default.
• W4200548846 creator A5076851275 @default.
• W4200548846 creator A5079071350 @default.
• W4200548846 creator A5083314956 @default.
• W4200548846 creator A5084106733 @default.
• W4200548846 creator A5085019532 @default.
• W4200548846 creator A5087307078 @default.
• W4200548846 creator A5089413595 @default.
• W4200548846 creator A5089659933 @default.
• W4200548846 date "2021-10-07" @default.
• W4200548846 modified "2023-10-18" @default.
• W4200548846 title "Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3)" @default.
• W4200548846 cites W1878991695 @default.
• W4200548846 cites W1985004174 @default.
• W4200548846 cites W2014330392 @default.
• W4200548846 cites W2046503049 @default.
• W4200548846 cites W2061120890 @default.
• W4200548846 cites W2110177517 @default.
• W4200548846 cites W2110826367 @default.
• W4200548846 cites W2114431960 @default.
• W4200548846 cites W2126087693 @default.
• W4200548846 cites W2128952811 @default.
• W4200548846 cites W2149564130 @default.
• W4200548846 cites W2159106700 @default.
• W4200548846 cites W2205328596 @default.
• W4200548846 cites W2262742107 @default.
• W4200548846 cites W2336100848 @default.
• W4200548846 cites W2530335997 @default.
• W4200548846 cites W2562753811 @default.
• W4200548846 cites W2566103724 @default.
• W4200548846 cites W2769489004 @default.
• W4200548846 cites W2802373788 @default.
• W4200548846 cites W2916926950 @default.
• W4200548846 cites W2917252704 @default.
• W4200548846 cites W2954102954 @default.
• W4200548846 cites W2962938985 @default.
• W4200548846 cites W2971217817 @default.
• W4200548846 cites W2971381437 @default.
• W4200548846 cites W3118646829 @default.
• W4200548846 cites W3124339251 @default.
• W4200548846 cites W4231972505 @default.
• W4200548846 cites W4292806894 @default.
• W4200548846 doi "https://doi.org/10.1093/mr/roab021" @default.
• W4200548846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34910203" @default.
• W4200548846 hasPublicationYear "2021" @default.
• W4200548846 type Work @default.
• W4200548846 citedByCount "3" @default.
• W4200548846 countsByYear W42005488462022 @default.
• W4200548846 crossrefType "journal-article" @default.
• W4200548846 hasAuthorship W4200548846A5006123817 @default.
• W4200548846 hasAuthorship W4200548846A5006840017 @default.
• W4200548846 hasAuthorship W4200548846A5010781580 @default.
• W4200548846 hasAuthorship W4200548846A5015953107 @default.
• W4200548846 hasAuthorship W4200548846A5027087975 @default.
• W4200548846 hasAuthorship W4200548846A5028937405 @default.
• W4200548846 hasAuthorship W4200548846A5034591782 @default.
• W4200548846 hasAuthorship W4200548846A5041444521 @default.
• W4200548846 hasAuthorship W4200548846A5066463687 @default.
• W4200548846 hasAuthorship W4200548846A5067668860 @default.
• W4200548846 hasAuthorship W4200548846A5075601927 @default.
• W4200548846 hasAuthorship W4200548846A5076851275 @default.
• W4200548846 hasAuthorship W4200548846A5079071350 @default.
• W4200548846 hasAuthorship W4200548846A5083314956 @default.
• W4200548846 hasAuthorship W4200548846A5084106733 @default.
• W4200548846 hasAuthorship W4200548846A5085019532 @default.
• W4200548846 hasAuthorship W4200548846A5087307078 @default.
• W4200548846 hasAuthorship W4200548846A5089413595 @default.
• W4200548846 hasAuthorship W4200548846A5089659933 @default.
• W4200548846 hasBestOaLocation W42005488461 @default.
• W4200548846 hasConcept C126322002 @default.
• W4200548846 hasConcept C197934379 @default.
• W4200548846 hasConcept C198451711 @default.
• W4200548846 hasConcept C203092338 @default.
• W4200548846 hasConcept C2777575956 @default.
• W4200548846 hasConcept C2781059491 @default.
• W4200548846 hasConcept C535046627 @default.
• W4200548846 hasConcept C71924100 @default.
• W4200548846 hasConcept C90924648 @default.
• W4200548846 hasConceptScore W4200548846C126322002 @default.
• W4200548846 hasConceptScore W4200548846C197934379 @default.
• W4200548846 hasConceptScore W4200548846C198451711 @default.
• W4200548846 hasConceptScore W4200548846C203092338 @default.
• W4200548846 hasConceptScore W4200548846C2777575956 @default.
• W4200548846 hasConceptScore W4200548846C2781059491 @default.
• W4200548846 hasConceptScore W4200548846C535046627 @default.
• W4200548846 hasConceptScore W4200548846C71924100 @default.

• next